News
PureTech challenges Roche's Esbriet in head-to-head IPF tria...
Roche's idiopathic pulmonary fibrosis (IPF) therapy Esbriet is already being squeezed by its main rival in the market, and could come under renewed pressure if another competitor from PureT
